Related Experiment Video
Updated: Jul 6, 2026
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
[Bone metastases in lung cancer]
Asuka Tsuya1, Masahiro Fukuoka
1Shizuoka Cancer Center, Division of Thoracic Oncology.
Clinical Calcium
|April 2, 2008
Summary
Lung cancer frequently spreads to the bone, causing debilitating skeletal-related events. Effective lung cancer treatment is key to preventing and managing bone metastases and improving patient quality of life.
Area of Science:
- Oncology
- Orthopedic Oncology
Background:
- Bone metastasis is a common complication in advanced lung cancer, affecting 30-40% of patients.
- This complication leads to skeletal-related events (SREs) such as pain, fractures, and spinal cord compression, significantly reducing quality of life (QOL).
Purpose of the Study:
- To review the incidence, complications, and current treatment strategies for bone metastases in lung cancer patients.
Main Methods:
- This abstract is based on a review of existing literature regarding lung cancer bone metastasis.
Main Results:
- The median survival time for patients with bone metastases is 6-7 months.
- Skeletal-related events are frequent and severely impact QOL.
- Systemic chemotherapy for primary lung cancer is the cornerstone of treatment for bone metastasis.
Conclusions:
- Effective management of lung cancer is crucial for preventing and treating bone metastases.
- Direct treatments for bone metastases include radiation therapy, surgery, and bisphosphonates.
